Yongqi Zhen

933 total citations
30 papers, 691 citations indexed

About

Yongqi Zhen is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Yongqi Zhen has authored 30 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Yongqi Zhen's work include Autophagy in Disease and Therapy (8 papers), Bioactive Natural Diterpenoids Research (4 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Yongqi Zhen is often cited by papers focused on Autophagy in Disease and Therapy (8 papers), Bioactive Natural Diterpenoids Research (4 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Yongqi Zhen collaborates with scholars based in China and United States. Yongqi Zhen's co-authors include Lan Zhang, Leilei Fu, Xian‐Li Zhou, Feng Gao, Bo Liu, Guan Wang, Liang Ouyang, Jin Zhang, Dejuan Sun and Lingjuan Zhu and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Science Advances.

In The Last Decade

Yongqi Zhen

30 papers receiving 689 citations

Peers

Countries citing papers authored by Yongqi Zhen

Since Specialization

Citations

This map shows the geographic impact of Yongqi Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongqi Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongqi Zhen more than expected).

Fields of papers citing papers by Yongqi Zhen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongqi Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongqi Zhen. The network helps show where Yongqi Zhen may publish in the future.

Co-authorship network of co-authors of Yongqi Zhen

This figure shows the co-authorship network connecting the top 25 collaborators of Yongqi Zhen. A scholar is included among the top collaborators of Yongqi Zhen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongqi Zhen. Yongqi Zhen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	N‐Heterocyclic Carbene Organocatalysis Enabled Modular Synthesis of Fluorinated Isoflavonoids to Suppress Proliferation and Migration in Breast Cancer Cells	Advanced Science	Yanqing Liu, Leilei Fu et al.	2
2	Avicularin inhibits ferroptosis and improves cognitive impairments in Alzheimer's disease by modulating the NOX4/Nrf2 axis	Phytomedicine	Zixiang Li, Yingying Lu et al.	14
3	Late-stage modification of complex drug: Base-controlled Pd-catalyzed regioselective synthesis and bioactivity of arylated osimertinibs	Science Advances	Yongqi Zhen, Dongbo Wu et al.	8
4	Small-molecule inhibitor of Fam20C in combination with paclitaxel suppresses tumor growth by LIF-JAK2/STAT3-modulated apoptosis in triple-negative breast cancer	Journal of the Taiwan Institute of Chemical Engineers	Yongqi Zhen, Zixiang Li et al.	5
5	Discovery of a novel dual-target inhibitor of CDK12 and PARP1 that induces synthetic lethality for treatment of triple-negative breast cancer	European Journal of Medicinal Chemistry	Lan Zhang, Yongqi Zhen et al.	11
6	Deciphering the multifunctional role of dual leucine zipper kinase (DLK) and its therapeutic potential in disease	European Journal of Medicinal Chemistry	Zhijia Li, Yingying Lu et al.	5
7	Flubendazole Enhances the Inhibitory Effect of Paclitaxel via HIF1α/PI3K/AKT Signaling Pathways in Breast Cancer	International Journal of Molecular Sciences	Yuxin Zhou, Minru Liao et al.	5
8	Deep Learning Promotes the Screening of Natural Products with Potential Microtubule Inhibition Activity	ACS Omega	Weijia Wang, Bo Yin et al.	9
9	Flubendazole induces mitochondrial dysfunction and DRP1-mediated mitophagy by targeting EVA1A in breast cancer	Cell Death and Disease	Yongqi Zhen, Jiahui Zhang et al.	37
10	BL-918, a small-molecule activator of ULK1, induces cytoprotective autophagy for amyotrophic lateral sclerosis therapy	Acta Pharmacologica Sinica	Wei Liu, Shiou Zhu et al.	13
11	Autophagy and beyond: Unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications	Acta Pharmaceutica Sinica B	Ling Zou, Minru Liao et al.	53
12	Deconvoluting the Complexity of Reactive Oxygen Species (ROS) in Neurodegenerative Diseases	Frontiers in Neuroanatomy	Yuxin Zhou, Yongqi Zhen et al.	32
13	Late-Stage Modification of Medicine: Pd-Catalyzed Direct Synthesis and Biological Evaluation of N-Aryltacrine Derivatives	ACS Omega	Yongqi Zhen, Zhenxiang He et al.	11
14	Isolation, Structure Elucidation, Semi-Synthesis, and Structural Modification of C₁₉-Diterpenoid Alkaloids from Aconitum apetalum and Their Neuroprotective Activities	Journal of Natural Products	Yongqi Zhen, Lan Zhang et al.	28
15	Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions	Acta Pharmaceutica Sinica B	Leilei Fu, Wenke Jin et al.	49
16	Diarylheptanoid: A privileged structure in drug discovery	Fitoterapia	Dejuan Sun, Lingjuan Zhu et al.	37
17	Designing an eEF2K-Targeting PROTAC small molecule that induces apoptosis in MDA-MB-231 cells	European Journal of Medicinal Chemistry	Yao Liu, Yongqi Zhen et al.	23
18	Design, synthesis and biological evaluation of benzamide derivatives as novel NTCP inhibitors that induce apoptosis in HepG2 cells	Bioorganic & Medicinal Chemistry Letters	Yongqi Zhen, Leilei Fu et al.	11
19	Ferulin C triggers potent PAK1 and p21-mediated anti-tumor effects in breast cancer by inhibiting Tubulin polymerization in vitro and in vivo	Pharmacological Research	Dahong Yao, Dabo Pan et al.	40
20	A novel small-molecule activator of Sirtuin-1 induces autophagic cell death/mitophagy as a potential therapeutic strategy in glioblastoma	Cell Death and Disease	Zhiqiang Yao, Xin Zhang et al.	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact